 @article{Sun_2020, title={Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib}, volume={80}, ISSN={1538-7445}, url={http://dx.doi.org/10.1158/0008-5472.CAN-20-1634}, DOI={10.1158/0008-5472.can-20-1634}, number={21}, journal={Cancer Research}, publisher={American Association for Cancer Research (AACR)}, author={Sun, Yuting and Meyers, Brooke A. and Czako, Barbara and Leonard, Paul and Mseeh, Faika and Harris, Angela L. and Wu, Qi and Johnson, Sarah and Parker, Connor A. and Cross, Jason B. and Di Francesco, Maria Emilia and Bivona, Benjamin J. and Bristow, Christopher A. and Burke, Jason P. and Carrillo, Caroline C. and Carroll, Christopher L. and Chang, Qing and Feng, Ningping and Gao, Guang and Gera, Sonal and Giuliani, Virginia and Huang, Justin K. and Jiang, Yongying and Kang, Zhijun and Kovacs, Jeffrey J. and Liu, Chiu-Yi and Lopez, Anastasia M. and Ma, Xiaoyan and Mandal, Pijus K. and McAfoos, Timothy and Miller, Meredith A. and Mullinax, Robert A. and Peoples, Michael and Ramamoorthy, Vandhana and Seth, Sahil and Spencer, Nakia D. and Suzuki, Erika and Williams, Christopher C. and Yu, Simon S. and Zuniga, Andy M. and Draetta, Giulio F. and Marszalek, Joseph R. and Heffernan, Timothy P. and Kohl, Nancy E. and Jones, Philip}, year={2020}, month=nov, pages={4840â€“4853} }
